Rigel Pharmaceuticals Net Non-Operating Interest Income Expense (Quarterly) Insights

Rigel Pharmaceuticals, Inc. (RIGL)

42.93 +0.10 (+0.23%) USD | NASDAQ | Dec 31, 15:46

View Net Non-Operating Interest Income Expense (Quarterly) for RIGL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Non-Operating Interest Income Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

Start Trial

Eli Lilly & Co.	Upgrade
Catalyst Pharmaceuticals, Inc.	Upgrade
Perspective Therapeutics, Inc.	Upgrade
Nektar Therapeutics	Upgrade
Vertex Pharmaceuticals, Inc.	Upgrade